Biosimilar Monoclonal Antibodies Market to Reach Valuation of 15200 Million US$ by the End of 2025 : QY Research
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
View full press release